Pineapple Express Cannabis (PNXP) Non-Current Debt (2024)
Pineapple Express Cannabis' (PNXP) quarterly Non-Current Debt came in at $5.0 million in Q2 2024.
Pineapple Express Cannabis (PNXP) Non-Current Debt (2024) Analysis & Trends
Pineapple Express Cannabis has disclosed Non-Current Debt across 1 years of filings, most recently posting $5.0 million for Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Pineapple Express Cannabis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 4.97 Mn |
| Apr 30, 2024 | 4.97 Mn |